261 related articles for article (PubMed ID: 31404602)
1. Erlotinib loaded chitosan nanoparticles: Formulation, physicochemical characterization and cytotoxic potential.
Pandey P; Dua K; Dureja H
Int J Biol Macromol; 2019 Oct; 139():1304-1316. PubMed ID: 31404602
[TBL] [Abstract][Full Text] [Related]
2. Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system.
Pandey P; Chellappan DK; Tambuwala MM; Bakshi HA; Dua K; Dureja H
Int J Biol Macromol; 2019 Dec; 141():596-610. PubMed ID: 31494160
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer.
Vaidya B; Parvathaneni V; Kulkarni NS; Shukla SK; Damon JK; Sarode A; Kanabar D; Garcia JV; Mitragotri S; Muth A; Gupta V
Int J Biol Macromol; 2019 Feb; 122():338-347. PubMed ID: 30401652
[TBL] [Abstract][Full Text] [Related]
4. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
[TBL] [Abstract][Full Text] [Related]
5. Development, In Vitro Characterization, Antitumor and Aerosol Performance Evaluation of Respirable Prepared by Self-nanoemulsification Method.
Naseri N; Zakeri-Milani P; Hamishehkar H; Pilehvar-Soltanahmadi Y; Valizadeh H
Drug Res (Stuttg); 2017 Jun; 67(6):343-348. PubMed ID: 28288490
[TBL] [Abstract][Full Text] [Related]
6. Thermo-sensitive chitosan copolymer-gold hybrid nanoparticles as a nanocarrier for delivery of erlotinib.
Fathi M; Sahandi Zangabad P; Barar J; Aghanejad A; Erfan-Niya H; Omidi Y
Int J Biol Macromol; 2018 Jan; 106():266-276. PubMed ID: 28802850
[TBL] [Abstract][Full Text] [Related]
7. Development and Characterization of Gefitinib Loaded Polymeric Nanoparticles by Ionic Gelation Method.
Gupta M; Marwaha RK; Dureja H
Pharm Nanotechnol; 2017; 5(4):301-309. PubMed ID: 28982345
[TBL] [Abstract][Full Text] [Related]
8. Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery.
Saroha A; Pandey P; Kaushik D
Pharm Nanotechnol; 2017; 5(4):310-316. PubMed ID: 28847270
[TBL] [Abstract][Full Text] [Related]
9. Formulation, characterization and in vitro release study of 5-fluorouracil loaded chitosan nanoparticles.
Samy M; Abd El-Alim SH; Rabia AEG; Amin A; Ayoub MMH
Int J Biol Macromol; 2020 Aug; 156():783-791. PubMed ID: 32320805
[TBL] [Abstract][Full Text] [Related]
10. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
11. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR
Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085
[TBL] [Abstract][Full Text] [Related]
12. Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay.
Öztürk AA; Kıyan HT
Microvasc Res; 2020 Mar; 128():103961. PubMed ID: 31758946
[TBL] [Abstract][Full Text] [Related]
13. Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity.
Bin-Jumah M; Gilani SJ; Jahangir MA; Zafar A; Alshehri S; Yasir M; Kala C; Taleuzzaman M; Imam SS
Int J Nanomedicine; 2020; 15():7861-7875. PubMed ID: 33116505
[TBL] [Abstract][Full Text] [Related]
14. Characterization and carboplatin loaded chitosan nanoparticles for the chemotherapy against breast cancer in vitro studies.
Khan MA; Zafaryab M; Mehdi SH; Quadri J; Rizvi MM
Int J Biol Macromol; 2017 Apr; 97():115-122. PubMed ID: 28082219
[TBL] [Abstract][Full Text] [Related]
15. Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy.
Saravanakumar K; Sathiyaseelan A; Mariadoss AVA; Jeevithan E; Hu X; Shin S; Wang MH
Carbohydr Polym; 2020 Oct; 245():116407. PubMed ID: 32718591
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effects of boswellic acid-loaded chitosan nanoparticles on human lung cancer cell line A549.
Solanki N; Mehta M; Chellappan DK; Gupta G; Hansbro NG; Tambuwala MM; Aa Aljabali A; Paudel KR; Liu G; Satija S; Hansbro PM; Dua K; Dureja H
Future Med Chem; 2020 Nov; 12(22):2019-2034. PubMed ID: 33124483
[No Abstract] [Full Text] [Related]
17. Carboxymethyl gum kondagogu-chitosan polyelectrolyte complex nanoparticles: preparation and characterization.
Kumar A; Ahuja M
Int J Biol Macromol; 2013 Nov; 62():80-4. PubMed ID: 23994791
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobic lapatinib encapsulated dextran-chitosan nanoparticles using a toxic solvent free method: fabrication, release property & in vitro anti-cancer activity.
Mobasseri R; Karimi M; Tian L; Naderi-Manesh H; Ramakrishna S
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():413-421. PubMed ID: 28254312
[TBL] [Abstract][Full Text] [Related]
19. Interfacial Phenomenon Based Biocompatible Alginate-Chitosan Nanoparticles Containing Isoniazid and Pyrazinamide.
Kushwaha K; Dwivedi H
Pharm Nanotechnol; 2018; 6(3):209-217. PubMed ID: 29938624
[TBL] [Abstract][Full Text] [Related]
20. Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System.
Brar V; Kaur G
Pharm Nanotechnol; 2018; 6(3):180-191. PubMed ID: 30101724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
